Drug Shortage Report for APO-DIVALPROEX

Last updated on 2022-01-14 History
Report ID 152307
Drug Identification Number 02239699
Brand name APO-DIVALPROEX
Common or Proper name DIVALPROEX
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) VALPROIC ACID
Strength(s) 250MG
Dosage form(s) TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED)
Route of administration ORAL ORAL
Packaging size 100 BTL
ATC code N03AG
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-01-03
Estimated end date 2022-01-28
Actual end date
Shortage status Actual shortage
Updated date 2022-01-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-01-07 English Compare
v2 2022-01-07 French Compare
v3 2022-01-14 English Compare
v4 2022-01-14 French Compare

Showing 1 to 4 of 4